PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.93%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-29.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
89.00%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
89.00%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
103.86%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
105.56%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
105.56%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.07%
Slight or no buybacks while ADI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.33%
Slight or no buyback while ADI is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-3.01%
Dividend reduction while ADI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-109.49%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-487.33%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
20.18%
10Y revenue/share CAGR under 50% of ADI's 168.83%. Michael Burry would suspect a lasting competitive disadvantage.
8.64%
5Y revenue/share CAGR under 50% of ADI's 84.42%. Michael Burry would suspect a significant competitive gap or product weakness.
-27.24%
Negative 3Y CAGR while ADI stands at 133.57%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
-140.49%
Negative 5Y OCF/share CAGR while ADI is at 656.25%. Joel Greenblatt would question the firm’s operational model or cost structure.
-118.39%
Negative 3Y OCF/share CAGR while ADI stands at 113.31%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-89.63%
Negative 10Y net income/share CAGR while ADI is at 0.00%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-87.29%
Negative 5Y net income/share CAGR while ADI is 361.46%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-95.45%
Negative 3Y CAGR while ADI is 175.77%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
176.77%
5Y equity/share CAGR 1.25-1.5x ADI's 148.80%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
73.88%
Below 50% of ADI's 204.57%. Michael Burry suspects a serious short-term disadvantage in building book value.
88.03%
Dividend/share CAGR of 88.03% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
40.38%
Dividend/share CAGR of 40.38% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
36.61%
3Y dividend/share CAGR of 36.61% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-2.29%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
4.58%
Inventory growth well above ADI's 6.86%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-4.42%
Negative asset growth while ADI invests at 3.19%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.99%
Under 50% of ADI's 4.87%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.24%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-55.74%
Our R&D shrinks while ADI invests at 4.36%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-10.57%
We cut SG&A while ADI invests at 9.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.